Parkman Healthcare Partners LLC Catalyst Biosciences, Inc. Transaction History

Parkman Healthcare Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.91 - $4.16 $121,438 - $555,147	-133,449 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.78 - $5.18 $982,800 - $1.35 Million	-260,000 Reduced 66.08%	133,449 $548,000
Q2 2021 Aug 13, 2021	BUY	$4.1 - $5.33 $7,507 - $9,759	1,831 Added 0.47%	393,449 $1.7 Million
Q1 2021 May 14, 2021	BUY	$4.93 - $7.15 $998,113 - $1.45 Million	202,457 Added 107.03%	391,618 $1.97 Million
Q4 2020 Feb 12, 2021	SELL	$4.55 - $7.29 $87,892 - $140,820	-19,317 Reduced 9.27%	189,161 $1.19 Million
Q3 2020 Nov 13, 2020	SELL	$4.22 - $6.04 $28,522 - $40,824	-6,759 Reduced 3.14%	208,478 $896,000
Q1 2020 May 15, 2020	BUY	$3.5 - $8.51 $753,329 - $1.83 Million	215,237 New	215,237 $941,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.